First National Bank of Hutchinson’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,522
Closed -$360K 99
2024
Q2
$360K Sell
2,522
-522
-17% -$69.2K 0.23% 77
2024
Q1
$391K Buy
3,044
+52
+2% +$6.19K 0.26% 79
2023
Q4
$310K Sell
2,992
-900
-23% -$89K 0.22% 81
2023
Q3
$354K Buy
3,892
+36
+0.9% +$3.17K 0.27% 83
2023
Q2
$312K Buy
3,856
+64
+2% +$5.23K 0.23% 92
2023
Q1
$302K Sell
3,792
-1,946
-34% -$138K 0.24% 94
2022
Q4
$388K Hold
5,738
0.33% 73
2022
Q3
$286K Buy
5,738
+162
+3% +$8.68K 0.23% 88
2022
Q2
$311K Buy
5,576
+20
+0.4% +$1.11K 0.23% 80
2022
Q1
$308K Buy
5,556
+40
+0.7% +$2.05K 0.18% 93
2021
Q4
$309K Buy
5,516
+172
+3% +$9.32K 0.18% 98
2021
Q3
$257K Hold
5,344
0.14% 110
2021
Q2
$224K Buy
+5,344
New +$207K 0.12% 123
2016
Q4
Sell
-31,014
Closed -$648K 86
2016
Q3
$648K Sell
31,014
-1,312
-4% -$32.5K 0.41% 26
2016
Q2
$844K Sell
32,326
-464
-1% -$12.7K 0.56% 23
2016
Q1
$871K Sell
32,790
-3,832
-10% -$103K 0.55% 29
2015
Q4
$1.03M Buy
36,622
+2,882
+9% +$79.8K 0.66% 25
2015
Q3
$953K Buy
33,740
+1,798
+6% +$50.9K 0.65% 22
2015
Q2
$902K Buy
31,942
+2,390
+8% +$67.2K 0.58% 25
2015
Q1
$789K Buy
29,552
+512
+2% +$11.8K 0.44% 31
2014
Q4
$614K Buy
29,040
+1,210
+4% +$27K 0.35% 36
2014
Q3
$663K Sell
27,830
-34
-0.1% -$782 0.41% 34
2014
Q2
$644K Buy
27,864
+4,074
+17% +$89.9K 0.39% 35
2014
Q1
$543K Buy
23,790
+5,460
+30% +$116K 0.34% 38
2013
Q4
$339K Buy
18,330
+610
+3% +$10.6K 0.22% 54
2013
Q3
$300K Sell
17,720
-27,680
-61% -$466K 0.21% 60
2013
Q2
$704K Buy
+45,400
New +$756K 0.25% 38

Other funds holding NVO

First National Bank of Hutchinson's NVO Position: Q3 2024 in Review

First National Bank of Hutchinson sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 2,522 shares — an estimated $360K sold.

First National Bank of Hutchinson first reported a position in NVO in Q2 2013 and held it in 27 quarters. The position peaked at $1.03M in Q4 2015. 1,786 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • First National Bank of Hutchinson reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • First National Bank of Hutchinson sold 2,522 Novo Nordisk shares in Q3 2024, an estimated $360K.
  • First National Bank of Hutchinson first reported a position in Novo Nordisk in Q2 2013 and held it in 27 quarters.
  • First National Bank of Hutchinson's Novo Nordisk position peaked at $1.03M in Q4 2015.
  • 1,786 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on First National Bank of Hutchinson's 13F filing for Q3 2024, filed 22 Oct 2024.